Therefore, the primary objectives of this study were to characterize the immunohistochemical expression of DARPP-32 isoforms in canine lung adenocarcinoma, and to evaluate associations with clinical variables, EGFR and VEGFR2 immunohistochemical expression, and outcome. The gene discussed is EGFR; the disease is lung adenocarcinoma.